(1)
Haznedaroglu, I. MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML). MJHID 2013, 6, e2014009.